Is a complete CBLL research report available?

No complete published report is available for CeriBell, Inc. (CBLL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CeriBell, Inc. (CBLL)

NASDAQ: CBLL · USD

$27.2

-0.07 (-0.3%)· Recorded snapshot

Market cap	1B
Revenue (ttm)	102M
Net income (ttm)	-66M
EPS (ttm)	-$1.76
Shares out	38.4M
Volume	673,779
Beta	0.93

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 102M
Net income (ttm): -66M
EPS (ttm): -$1.76
Market cap: 1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001861107
Company name	CeriBell, Inc.
Country	United States
Country code	US
CUSIP number	15678C102
Earnings date	2026-11-03
Earnings time	amc
Employees	327
Employees change	46
Employees growth	16.37%
Enterprise value	$934.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2024-10-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US15678C1027
Last 10-K release date	2026-02-24
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1B
Market cap category	Small-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$27.15
Price currency	USD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	CBLL
U.S. state	California
Website	https://www.ceribell.com

Metric

Value

Amount currency

USD

CIK code

0001861107

Company name

CeriBell, Inc.

Country

United States

Country code

CUSIP number

15678C102

Earnings date

2026-11-03

Earnings time

amc

Employees

327

Employees change

Employees growth

16.37%

Enterprise value

$934.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Medical Devices

IPO date

2024-10-11

Is primary listing

Yes

Is SPAC

ISIN number

US15678C1027

Last 10-K release date

2026-02-24

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1B

Market cap category

Small-Cap

Next earnings date

2026-11-03

Options

Yes

Price

$27.15

Price currency

USD

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-28

Symbol

CBLL

U.S. state

California

Website

https://www.ceribell.com

Metric	Value
Earnings yield	-6.5%
EV/Sales	9.18x
FCF / EV yield	-5.99%
FCF yield	-5.38%
Forward EV/Sales	7.15x
Forward P/S	7.97x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	8.11x
P/S ratio	10.23x
Price / tangible book value	8.13x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-6.5%

EV/Sales

9.18x

FCF / EV yield

-5.99%

FCF yield

-5.38%

Forward EV/Sales

7.15x

Forward P/S

7.97x

Industry forward P/E

19.81x

Industry P/E

39.28x

P/B ratio

8.11x

P/S ratio

10.23x

Price / tangible book value

8.13x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-68.62%
EBITDA margin	-67.48%
Gross margin	88.9%
Operating margin	-68.62%
Pretax margin	-64.73%
Profit margin	-64.73%
Profit per employee	$-201,826
Revenue per employee	$311,817
ROA	-23.38%
ROCE	-46.91%
ROE	-43.93%
ROIC	-25.43%
SBC / revenue	16.11%

Metric

Value

EBIT margin

-68.62%

EBITDA margin

-67.48%

Gross margin

88.9%

Operating margin

-68.62%

Pretax margin

-64.73%

Profit margin

-64.73%

Profit per employee

$-201,826

Revenue per employee

$311,817

ROA

-23.38%

ROCE

-46.91%

ROE

-43.93%

ROIC

-25.43%

SBC / revenue

16.11%

Metric	Value
EPS growth years	3
Gross profit growth	33.42%
Gross profit growth (Q)	38.84%
Net income growth years	0
Revenue growth	31.7%
Revenue growth (Q)	32.54%
Revenue growth (QoQ)	6.05%
Revenue growth quarters	8
Revenue growth years	3

Metric

Value

EPS growth years

Gross profit growth

33.42%

Gross profit growth (Q)

38.84%

Net income growth years

Revenue growth

31.7%

Revenue growth (Q)

32.54%

Revenue growth (QoQ)

6.05%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-2.1M
Depreciation and amortization	$1.2M
EBIT	$-70M
EBITDA	$-68.8M
EPS	$-1.76
FCF per share	$-1.46
Financing cash flow	$5.6M
Free cash flow	$-56.1M
Free cash flow minus SBC	$-72.5M
Gross profit	$90.6M
Investing cash flow	$41M
Net cash flow	$-7.5M
Net income	$-66M
Operating cash flow minus SBC	$-70.5M
Operating income	$-70M
Revenue	$102M
Stock-based compensation	$16.4M

Metric

Value

Capital expenditures

$-2.1M

Depreciation and amortization

$1.2M

EBIT

$-70M

EBITDA

$-68.8M

EPS

$-1.76

FCF per share

$-1.46

Financing cash flow

$5.6M

Free cash flow

$-56.1M

Free cash flow minus SBC

$-72.5M

Gross profit

$90.6M

Investing cash flow

$41M

Net cash flow

$-7.5M

Net income

$-66M

Operating cash flow minus SBC

$-70.5M

Operating income

$-70M

Revenue

$102M

Stock-based compensation

$16.4M

Metric	Value
Altman Z-Score	8.02
Book value per share	$3.36
Debt / equity	0.17
Interest coverage	-38.57
Long-term assets	$8.5M
Long-term liabilities	$20.8M
Net cash (debt)	$107.4M
Net cash / market cap	10.29%
Net cash growth	-31.13%
Net debt / equity	-0.84
Piotroski F-Score	2
Property, plant and equipment	$6.2M
Shareholders' equity	$128.3M
Tangible book value	$128.3M
Tangible book value per share	$3.36
Total assets	$166.3M
Total cash	$129.3M
Total debt	$21.9M
Total liabilities	$38M
WACC	9.31%

Metric

Value

Altman Z-Score

8.02

Book value per share

$3.36

Debt / equity

0.17

Interest coverage

-38.57

Long-term assets

$8.5M

Long-term liabilities

$20.8M

Net cash (debt)

$107.4M

Net cash / market cap

10.29%

Net cash growth

-31.13%

Net debt / equity

-0.84

Piotroski F-Score

Property, plant and equipment

$6.2M

Shareholders' equity

$128.3M

Tangible book value

$128.3M

Tangible book value per share

$3.36

Total assets

$166.3M

Total cash

$129.3M

Total debt

$21.9M

Total liabilities

$38M

WACC

9.31%

Metric	Value
Asset turnover	0.55
Current assets	$157.8M
Current liabilities	$17.2M
Current ratio	9.18
Inventory turnover	1.78
Net working capital	$12.6M
Quick ratio	8.45
Working capital	$140.6M
Working capital turnover	0.63

Metric

Value

Asset turnover

0.55

Current assets

$157.8M

Current liabilities

$17.2M

Current ratio

9.18

Inventory turnover

1.78

Net working capital

$12.6M

Quick ratio

8.45

Working capital

$140.6M

Working capital turnover

0.63

Metric	Value
Buyback yield / dilution	-37.38%
Dividend yield	0%
Shareholder yield	-37.38%

Metric

Value

Buyback yield / dilution

-37.38%

Dividend yield

Shareholder yield

-37.38%

Metric	Value
150-day SMA	$21.00
1D price change	-0.26%
1M price change	14.82%
1M total return	14.82%
1W price change	-1.73%
1W total return	-1.73%
1Y price change	111.02%
1Y return CAGR	111.12%
1Y total return	111.02%
20-day SMA	$25.70
200-day SMA	$20.74
3M price change	50.03%
3M total return	50.03%
50-day SMA	$24.82
50-day SMA vs 200-day SMA	50over200
52-week high	$28.11
52-week high date	2026-10-21
52-week low	$10.85
52-week low date	2025-11-04
6M price change	28.67%
6M total return	28.67%
All-time high	$32.75
All-time high date	2024-12-12
All-time low	$10.01
All-time low date	2025-04-10
Average true range (ATR)	$1.24
Average volume	496.7K
Beta (1Y)	0.67
Beta (2Y)	0.83
Beta (5Y)	0.93
Change from 52-week high	-3.42%
Change from 52-week low	150.23%
Change from all-time high	-16.94%
Change from all-time low	171.73%
Change from open	1.15%
Day's gap	-1.4%
Dollar volume	$18.3M
High price	$27.57
Low price	$26.84
Monthly RSI	59.6
Open price	$26.84
Position in 52-week range	42.47%
Previous close	$27.22
Price vs 150-day SMA	29.52%
Price vs 20-day SMA	5.84%
Price vs 200-day SMA	31.18%
Price vs 50-day SMA	9.6%
Relative volume	1.36
Return from IPO open	16.87%
Return from IPO price	59.91%
RSI	59.5
Sharpe ratio	1.63
Sortino ratio	2.67
Volume	673.8K
Weekly RSI	69.15
YTD price change	24.03%
YTD total return	24.03%

Metric

Value

150-day SMA

$21.00

1D price change

-0.26%

1M price change

14.82%

1M total return

14.82%

1W price change

-1.73%

1W total return

-1.73%

1Y price change

111.02%

1Y return CAGR

111.12%

1Y total return

111.02%

20-day SMA

$25.70

200-day SMA

$20.74

3M price change

50.03%

3M total return

50.03%

50-day SMA

$24.82

50-day SMA vs 200-day SMA

50over200

52-week high

$28.11

52-week high date

2026-10-21

52-week low

$10.85

52-week low date

2025-11-04

6M price change

28.67%

6M total return

28.67%

All-time high

$32.75

All-time high date

2024-12-12

All-time low

$10.01

All-time low date

2025-04-10

Average true range (ATR)

$1.24

Average volume

496.7K

Beta (1Y)

0.67

Beta (2Y)

0.83

Beta (5Y)

0.93

Change from 52-week high

-3.42%

Change from 52-week low

150.23%

Change from all-time high

-16.94%

Change from all-time low

171.73%

Change from open

1.15%

Day's gap

-1.4%

Dollar volume

$18.3M

High price

$27.57

Low price

$26.84

Monthly RSI

59.6

Open price

$26.84

Position in 52-week range

42.47%

Previous close

$27.22

Price vs 150-day SMA

29.52%

Price vs 20-day SMA

5.84%

Price vs 200-day SMA

31.18%

Price vs 50-day SMA

9.6%

Relative volume

1.36

Return from IPO open

16.87%

Return from IPO price

59.91%

RSI

59.5

Sharpe ratio

1.63

Sortino ratio

2.67

Volume

673.8K

Weekly RSI

69.15

YTD price change

24.03%

YTD total return

24.03%

Metric	Value
Float	26.5M
Float percentage	69.17%
Shares change (QoQ)	0.98%
Shares change (YoY)	37.38%
Shares held by insiders	5.5%
Shares held by institutions	70.82%
Shares outstanding	38.4M
Short % of float	7.6%
Short % of shares	5.26%
Short ratio	5.7 days

Metric

Value

Float

26.5M

Float percentage

69.17%

Shares change (QoQ)

0.98%

Shares change (YoY)

37.38%

Shares held by insiders

5.5%

Shares held by institutions

70.82%

Shares outstanding

38.4M

Short % of float

7.6%

Short % of shares

5.26%

Short ratio

5.7 days

CeriBell, Inc. (CBLL)

Price

Financial snapshot

Fair-value bridge

Latest news · CBLL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CBLL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CBLL

Frequently asked questions